| Jun 21 |
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
|
| Jun 20 |
MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)
|
| Jun 7 |
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) 18% loss last week hit both individual investors who own 46% as well as institutions
|
| Jun 5 |
RBC recommends buying MindMed amid psychedelic stocks sell-off (update)
|
| Jun 5 |
MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors
|
| Jun 5 |
Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate
|
| Jun 5 |
Biggest stock movers today: WKME, CRWD, HPE, and more
|
| Jun 5 |
Psychedelic stocks fall as FDA panel rejects MDMA therapy
|
| May 31 |
Psychedelic stocks mixed as FDA comments on MDMA therapy
|
| May 30 |
Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
|
